CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers--findings from two independent populations
about
Susceptibility to human cancer: From the perspective of a pathologist.Association of CYP2A6 activity with lung cancer incidence in smokers: The multiethnic cohort studyPathways to precision medicine in smoking cessation treatments.UGT1A and UGT2B genetic variation alters nicotine and nitrosamine glucuronidation in european and african american smokers.Genetic determinants of CYP2A6 activity across racial/ethnic groups with different risks of lung cancer and effect on their smoking intensityDistribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction.CYP2A6 genetic polymorphisms and biomarkers of tobacco smoke constituents in relation to risk of lung cancer in the Singapore Chinese Health Study.Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai cohort study.CYP2A6 genotyping methods and strategies using real-time and end point PCR platforms.Variation in CYP2A6 Activity and Personalized Medicine.Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer.Lung Cancer Health Disparities.Association of genetic polymorphisms CYP2A6*2 rs1801272 and CYP2A6*9 rs28399433 with tobacco-induced lung Cancer: case-control study in an Egyptian population.
P2860
Q30250217-36A3B953-C810-4530-A593-8D930575F10CQ33728649-52AD2357-6DB9-4453-B03D-DDC5C7A84F18Q34527740-666AB717-D5E4-4FDC-BF8D-E1DE24AE697EQ34964392-B55F1D59-4AD9-4339-A364-3467BD8D8A16Q37238137-1F434986-DF83-464A-85F3-D83BEBBFECA3Q38683483-5EE57E43-C613-464E-A29F-02A98DE7ED38Q40342867-493E505A-06F1-4073-B1F3-790DFC863D51Q41054488-DFDE7446-7656-4835-B127-76B6DB280FBDQ41927477-5911FA44-4AE7-43A0-A541-665EF2A11EB5Q47163198-9D2CE682-873D-41E2-B412-D2EB18A14EA5Q47804236-ED4694AE-6654-4AB2-B89F-DD927C8A3799Q53177073-BB43A087-8C07-47B3-B873-279516D97B86Q53686438-8939D8F4-E63C-4637-9F1D-157E94DA4B7D
P2860
CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers--findings from two independent populations
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
CYP2A6 reduced activity gene v ...... om two independent populations
@ast
CYP2A6 reduced activity gene v ...... om two independent populations
@en
CYP2A6 reduced activity gene v ...... om two independent populations
@nl
type
label
CYP2A6 reduced activity gene v ...... om two independent populations
@ast
CYP2A6 reduced activity gene v ...... om two independent populations
@en
CYP2A6 reduced activity gene v ...... om two independent populations
@nl
prefLabel
CYP2A6 reduced activity gene v ...... om two independent populations
@ast
CYP2A6 reduced activity gene v ...... om two independent populations
@en
CYP2A6 reduced activity gene v ...... om two independent populations
@nl
P2093
P2860
P356
P1433
P1476
CYP2A6 reduced activity gene v ...... om two independent populations
@en
P2093
Catherine A Wassenaar
Margaret R Spitz
Melinda C Aldrich
Rachel F Tyndale
William J Blot
Yuanqing Ye
P2860
P304
P356
10.1093/CARCIN/BGU235
P407
P577
2014-11-21T00:00:00Z